Press releases

Russia to supply Sputnik V vaccine to Belarus for clinical trials in October

MOSCOW, 28 September (BelTA – TASS) - The Russian Direct Investment Fund (RDIF) will deliver the first batch of Russian coronavirus vaccine Sputnik V for clinical trials to Belarus in October, reads the statement from the RDIF.

"Vaccination of volunteers in Belarus will begin on 1 October as part of double-blind, randomized, placebo-controlled clinical trials of the Sputnik V vaccine. RDIF is funding these clinical trials in Belarus with the participation of 100 people who will be vaccinated against coronavirus with the vaccine developed by the Gamaleya National Research Institute of Epidemiology and Microbiology at the Healthcare Ministry of Russia," the statement reads.

The press service of the Belarusian Healthcare Ministry said that the ministry issued permission to conduct the multicenter clinical trials of the vaccine. “A group of experts approved trials protocol No. 04 Gam COVID Vac 2020 RB, it added. Today, the clinical centers to be involved in the trials are busy making arrangements and screening volunteers.

Belarus has become the first country to start clinical trials of the Sputnik V vaccine after its registration in Russia. “Clinical trials will be carried out in eight medical institutions selected as research centers in Belarus. Two Belarusian clinics have already received the first batches of the Sputnik V vaccine,” the fund added.

Similar clinical trials of the Sputnik V vaccine are planned in a number of other countries, including Brazil, India, Saudi Arabia Egypt and the United Arab Emirates. According to the fund, more than 50 countries in CIS, Europe, Asia, Middle East and Latin America have applied for Sputnik V. Earlier the fund announced supply agreements with Mexico for 32 million doses, with Brazil for up to 50 million doses, with India for 100 million doses and with Uzbekistan for up to 35 million doses.

print version

make home page

add to bookmarks